Knight Capital Group’s ANI Pharmaceuticals ANIP Stock Holding History

Knight Capital Group’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$13K	Buy	+2,231	New	+$15.6K	﹤0.01%	3206

Other funds holding ANIP

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Knight Capital Group's ANIP Position: Q2 2013 in Review

Knight Capital Group opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2013: 2,231 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #3206 among its holdings.

34 funds tracked by Wall St. Rank hold ANIP as of Q2 2013.

Knight Capital Group held 2,231 shares of ANI Pharmaceuticals worth $13K as of Q2 2013.
ANI Pharmaceuticals was a new Knight Capital Group position in Q2 2013.
ANI Pharmaceuticals made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3206 holding.
34 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.